Code

Description

Unit

USP-1347664

Irinotecan Related Compound E - (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

15 mg

USP-1347653

Irinotecan Related Compound D - (R)-9-[(1,4'Bipiperidine)-1'carboxyl]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin hydrochloride, trihydrate

15 mg

USP-1347642

Irinotecan Related Compound C - 11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride

10 mg

USP-1347631

Irinotecan Related Compound B - (S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

10 mg

USP-1347610

Irinotecan Related Compound A - (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

10 mg

USP-1347609

Irinotecan Hydrochloride

100 mg

USP-1347530

Ipratropium Bromide Related Compound C - (2-RS)-3-hydroxy-2-phenylpropanoic acid

15 mg

USP-1347529

Ipratropium Bromide Related Compound B - (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide

10 mg

USP-1347518

Ipratropium Bromide Related Compound A - endo-3-Hydroxy-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide

10 mg

USP-1347507

Ipratropium Bromide

100 mg